Researchers at Thomas Jefferson University identified a novel signaling pathway mediating aldosterone production, which promotes heart failure. Blocking beta-arrestin-1 could lead to lower aldosterone levels and alleviate negative remodeling processes in the injured heart.
Researchers identified proepithelin as a protein that encourages cell growth and migration in prostate cancer cells, especially androgen-independent ones. Proepithelin overexpression may serve as a clinical marker for prostate cancer diagnosis and a therapeutic target.
Researchers at Thomas Jefferson University found a biomarker, guanylyl cyclase 2C (GUCY2C), that predicts disease recurrence in colorectal cancer. The study revealed that 87.5% of patients had positive GUCY2C expression and 20.9% developed recurrent disease.
Researchers at Thomas Jefferson University discovered a key protein component involved in inflammation detection and reaction to cytoplasmic DNA produced by infections or tissue damage. AIM2, a tumor suppressor, induces cell death to prevent pathogen replication.
Research from Thomas Jefferson University reveals that African-American patients with colorectal cancer are more likely to present with advanced disease and have a worse five-year survival rate. Socioeconomic factors, including access to healthcare screening, may contribute to these disparities.
A pre-emptive skin regimen can significantly reduce skin-associated toxicities associated with panitumumab for metastatic colorectal cancer treatment. The study found that this approach reduced the incidence of grade 2 or higher skin toxicities by over 50%. Patients who received prophylactic treatment reported improved quality of life,...
Researchers at Thomas Jefferson University's Center for Translational Medicine successfully reversed heart damage in rats with heart failure using gene therapy. The treatment, which involves administering a peptide called βARKct, inhibited the activation of a kinase that contributes to heart failure deterioration.
A new angled gantry approach to coronary CT angiography significantly reduced breast radiation exposure by half. Researchers found that imaging the heart with an angled gantry acquisition reduced the overlap with the lower breast from 6.5cm to 3.2cm, warranting further machine development.
Dr. Scott Mintzer has received a $843,000 NIH grant to investigate the cardiovascular side effects of anti-seizure medications in patients with epilepsy and subarachnoid hemorrhage. The study aims to improve treatment outcomes while minimizing potential risks.
Researchers from Thomas Jefferson University reported that IDO2 enzyme is overexpressed in pancreatic cancer cells, potentially leading to targeted immunotherapy. Genetic analysis revealed that about 75% of patients have an active IDO2 enzyme, suggesting a novel therapeutic strategy.
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease. Lmx1a-positive cells with TrkB surface marker can be selected using magnetic-activated cell sorting or fluorescence-activated cell sorting.
Researchers at Thomas Jefferson University will conduct a single-site study of 200 AMD patients to determine the effectiveness of a treatment program designed to prevent depression and disability. The Low Vision Depression Prevention Trial aims to improve vision skills in people with AMD, thereby preventing depression and promoting ind...
Researchers developed a 'suicide gene' delivery approach that successfully kills pancreatic cancer cells by over 95 percent, targeting only cancer cells with minimal harm to normal ones. This innovative strategy uses mesothelin DNA linked to diphtheria toxin, effectively hijacking cancer cell machinery.
Scientists at Thomas Jefferson University have discovered a key mechanism of breast cancer metastasis, where a gene dubbed 'Dachshund' (DACH1) regulates the production of IL-8, a common inflammatory protein. Blocking this protein with an antibody completely halted breast cancer spread in mice.
Researchers at Thomas Jefferson University have developed a new type of colon cancer vaccine that reduces the spread of disease in mice. The vaccine targets mucosal cells and induces an immune response against cancer, leading to fewer metastases and prolonged survival.
A multicenter, randomized, double-blind study found that Chinese red yeast rice reduced the risk of repeat heart attacks and cardiovascular mortality by one-third. The study showed a significant reduction in cancer mortality as well.
Researchers at Jefferson University have identified a key signaling protein that enables prostate cancer cells to metastasize. Blocking this protein, Stat3, can prevent prostate cancer from spreading, offering new potential therapies.
A team of researchers at Thomas Jefferson University and Ohio State University Medical Center has identified a specific gene signature profile associated with metastasis. This signature is composed mainly of overexpressed microRNAs and may represent a new approach for diagnosing metastatic cancer.
Researchers at Thomas Jefferson University have developed a new ultrasound technique that targets areas of increased blood flow in the prostate gland, significantly reducing the number of unnecessary biopsies. The study found that targeted biopsies were twice as likely to detect cancer compared to conventional methods.
A research study has found that a simple blood test can indicate whether post-menopausal hormone therapies increase the risk of a heart attack. Women with favorable cholesterol levels were not at increased risk of developing heart problems while taking hormones, whereas those with unfavorable cholesterol levels were at higher risk.
Scientists at Thomas Jefferson University will study molecular mechanisms of cardiac injury leading to heart failure, as well as cellular and molecular mechanisms that promote repair in the adult failing heart. The four-lab project aims to find data that can be translated into novel therapeutic strategies.
Researchers found that thymoquinone blocked pancreatic cancer cell growth and killed cells by enhancing programmed cell death, with 80% of cancer cells killed. Thymoquinone also triggered epigenetic changes, including acetylation of histones, which could lead to new cancer treatments.
Researchers at Thomas Jefferson University discovered that a protective heart failure protein also regulates blood pressure. Lowering this protein's levels in animal models increased blood pressure. The study suggests S100A1 could be a novel therapeutic target for treating hypertension and heart failure.
Researchers at Thomas Jefferson University have found that common blood pressure medications can inhibit pancreatic cancer cell growth and cause cell death. The study suggests that these drugs may be part of a novel strategy to control the growth and spread of cancer.
Researchers found that nicotine increases osteopontin production, promoting cancer cell survival and spread. Elevated osteopontin levels have been detected in pancreatic cancer patients, suggesting a potential role in the cigarette smoking-pancreatic cancer connection.
Researchers at Thomas Jefferson University have identified a crucial signaling protein Gi that protects the heart during a heart attack. Blocking this protein increases heart damage in genetically engineered mice experiencing heart attacks.
Researchers found a correlation between smoking history and increased risk of aneurysm recanalization in patients treated with coil embolization. Cigarette smoking is the only factor consistently identified as a predisposition for cerebral aneurysms.
Researchers at Thomas Jefferson University have discovered that blocking the signaling protein Stat5 can effectively kill prostate cancer cells and inhibit tumor growth. This finding holds promise for treating advanced prostate cancer, particularly hormone-resistant cases.
A new clinical trial at Thomas Jefferson University aims to test the effectiveness of radioembolization using radiation-emitting beads in treating advanced liver cancer. The treatment, which blocks blood supply and emits targeted radiation, has shown promise in shrinking tumors and improving patient survival.
Researchers at Thomas Jefferson University have discovered that USP22 is crucial for controlling large-scale changes in gene expression in cancer cells. The study reveals that USP22 is necessary for the global changes in gene expression patterns that occur in these cells, making it a potential target for new anti-cancer drugs.
Scientists discovered that metastatic pancreatic cancer cells produce enough of the protein IDO to evade detection by the immune system, allowing them to spread in the body. This finding may lead to new ways to detect pancreatic cancer spreading to lymph nodes and enhance tumor immune therapy strategies.
Researchers at Thomas Jefferson University have found that nearly all recurrent prostate cancers resistant to hormone therapy activate a signaling protein called Stat5, making it a potential drug target. The convergence of two biological pathways may also contribute to the development of aggressive hormone-resistant tumors.
A recent survey reveals a significant gap in knowledge among primary care physicians regarding rare blood cancers like leukemia and lymphoma. The findings emphasize the importance of education and referrals to specialists in improving patient survival rates. As long-term cancer survivors, patients are at risk of developing second cance...
Researchers found that lead exposure in young rats hindered their ability to recover from brain injuries such as stroke. The study suggests that early lead exposure may compromise the brain's ability to compensate for injury and recover function.
Scientists at Jefferson Medical College have used PET imaging to observe hyperactive breast cancer genes in laboratory animals, marking a breakthrough in detecting and classifying cancer. This technology may help physicians identify breast tumors as early as possible and determine the appropriate treatment.
Researchers have identified a key pathway involved in autoinflammatory diseases, including arthritis and certain types of cancer. Mutant forms of the PSTPIP1 protein can activate pyrin, leading to excessive IL-1 beta production and inflammation.
Researchers at Thomas Jefferson University have found that the protein IL-27 can block the onset of symptoms in animals with an MS-like disease, suggesting it may be a potential tool for tempering over-active immune responses. Increasing IL-27 concentrations may help quell an over-active immune response and improve symptoms.
Researchers found that simultaneous treatment resulted in a five-year survival rate of 15.1 percent, compared to 10.6 percent with sequential therapy. The study's findings suggest that concurrent chemotherapy and radiation is the new standard of care for locally advanced non-small cell lung cancer.
A team of researchers at Thomas Jefferson University discovered stem cells in the intervertebral discs of humans and animals, suggesting a potential new approach to treating degenerative disc disease. The discovery could lead to the use of adult stem cells to repair damaged discs and alleviate lower back and neck pain.
Researchers at Thomas Jefferson University found that stereotactic radiation is an effective alternative to surgery for benign brain tumors called non-acoustic schwannomas. The study showed excellent local tumor control with minimal side effects, making it a promising treatment option.
Researchers at Jefferson University have discovered a tumor-blocking protein, pp32, that may be missing in aggressive forms of pancreatic cancer. The absent protein could eventually serve as a biomarker for the disease and a potential therapeutic target.
Researchers at Thomas Jefferson University found that HIV recruits cellular miRNA to control viral RNA translation, allowing the virus to remain dormant. Manipulating miRNA's inhibitory effect on HIV may lead to new treatment strategies against the virus.
Scientists at Jefferson University have found a new molecular evidence of the role of prolactin in breast cancer. The hormone stimulates a signaling pathway that may regulate the growth and survival of breast cancer cells. Inhibiting the Jak1 protein could represent a new drug target for treating breast cancer.
Researchers found that personalized interventions significantly improved colon cancer screening rates in primary care practices. Screening rates increased by 33-48% compared to usual care, with the most substantial improvements seen when personal messages addressed personal barriers to screening. The study suggests that a relatively si...
Immunology researchers at Thomas Jefferson University have successfully halted a lethal rabies infection in mice by opening the central nervous system's protective blood-brain barrier. This breakthrough could lead to improved treatment for late-stage rabies infections in humans, and may also shed light on other neurological diseases.
Researchers at Thomas Jefferson University found that colon cancer is caused by a lack of hormones that regulate intestinal epithelial cells. Hormone replacement therapy may prevent or treat the disease, shifting the focus from genetic to endocrine aspects.
Research at Thomas Jefferson University shows that African American women with breast cancer tend to have more advanced disease and poorer outcomes. The study found that these tumors are more often estrogen-receptor negative and express growth-promoting genes, leading to aggressive and invasive disease.
A trial found that circulating tumor cells in the blood of patients with metastatic prostate cancer can predict how well they will respond to chemotherapy. Patients with more than five tumor cells per blood sample had a worse prognosis, while those whose CTC number went down fared better.
Researchers at Jefferson Medical College found that a natural substance secreted by fat cells can protect blood vessels from inflammation, a factor in heart disease. Harnessing adiponectin's properties may someday help protect against blood vessel damage in patients with obesity and diabetes.
Studies found that small pieces of genetic material known as miRNAs are more likely to be located near genes affecting cancer susceptibility. This discovery could lead to new insights into cancer risk and potentially inform the development of targeted therapies.